# Denali Therapeutics Inc.: Form 8-K, filed Jul 26, 2021

- Company: [Denali Therapeutics Inc.](/companies/dnli.md) (CIK 1714899)
- Form: 8-K
- Filed: 2021-07-26
- Accepted by EDGAR: Jul 26, 2021, 08:29 ET
- Period: 2021-07-25
- Accession: 0001714899-21-000066
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1714899/000171489921000066/dnli-20210725.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1714899/000171489921000066/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1714899/000171489921000066/dnli-20210725.htm

Filed Jul 26, 2021.
Source: SEC EDGAR, the filing index for accession 0001714899-21-000066. Last ingested by Listed: Nov 3, 2026, 19:01 ET. No prices; not investment advice.
